title: Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy.
abstract: We describe a patient with widespread and progressive cutaneous sarcoidosis who was successfully treated with anti-tumor necrosis factor-alpha monoclonal antibody, infliximab, suggesting that inhibition of tumor necrosis factor-alpha may be useful as targeted treatment in cutaneous sarcoidosis.
authors.affiliation: Unit of Dermatology, Department of Medicine, Karolinska Institute, 171 76 Stockholm, Sweden.
authors.forename: Lotus
authors.initials: L
authors.lastname: Mallbris
authors.forename: Anders
authors.initials: A
authors.lastname: Ljungberg
authors.forename: Mari-Anne
authors.initials: MA
authors.lastname: Hedblad
authors.forename: Per
authors.initials: P
authors.lastname: Larsson
authors.forename: Mona
authors.initials: M
authors.lastname: Ståhle-Bäckdahl
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D018450:Disease Progression; D005838:Genotype; D006801:Humans; D000069285:Infliximab; D008297:Male; D012507:Sarcoidosis / Q000188:drug therapy* / Q000235:genetics; D012871:Skin Diseases / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha
chemical_list: D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab